Extracellular adenosine signaling in bone health and disease

Curr Opin Pharmacol. 2023 Apr 10;70:102378. doi: 10.1016/j.coph.2023.102378. Online ahead of print.ABSTRACTPurinergic signaling is a key molecular pathway in the maintenance of bone health and regeneration. P1 receptor signaling, which is activated by extracellular adenosine, has emerged as a key metabolic pathway that regulates bone tissue formation, function, and homeostasis. Extracellular adenosine is mainly produced by ectonucleotidases, and alterations in the function of these enzymes or compromised adenosine generation can result in bone disorders, such as osteoporosis and impaired fracture healing. This mini review discusses the key role played by adenosine in bone health and how its alterations contribute to bone diseases, as well as potential therapeutic applications of exogenous adenosine to combat bone diseases like osteoporosis and injury.PMID:37044008 | DOI:10.1016/j.coph.2023.102378
Source: Current Opinion in Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research